Across TCGA pan-cancer cohorts, RTN4RL2 mass-spec protein is linked to patient survival in 2 of 34 cancer types, making it a survival-associated RTN4RL2 data layer compared with 18 for mass-spec protein and 1 for mutation status.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher RTN4RL2 mass-spec protein is associated with better overall survival. In most high-consensus cancer types, elevated RTN4RL2 expression acts as an unfavorable survival marker, although some lineages such as LUAD and GBM show a favorable association.

LUAD and GBM are the cancer types where RTN4RL2 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Median	II,III,IV	1.000	0.467	.018	8	view →
GBM	DFS	Tertile	All	0.874	0.628	.010	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: RTN4RL2 tumor-vs-normal RNA expression · all RTN4RL2 data types